-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: George Goodno
George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.
Follow him on Twitter @ggoodno
Latest Posts
BayBio Announces Lifetime Achievement DiNA Award Recipient
Dr. Michael Hunkapiller has been named BayBio’s 2011 Lifetime Achievement DiNA Award recipient. He will be honored on Thursday, November 3rd, at the 2011 Pantheon Awards Ceremony, an annual program hosted by BayBio, a life science trade association representing the industry in Northern California. From the invention of the DNA sequencer during his days at Caltech, to the introduction of first automated DNA sequencer in 1986 and the realization of the Human Genome Mapping Project Read More >
Incentivizing Biotech Growth; States and Regions Look to Stand Out from the Crowd
The United States’ prolonged economic woes have drastically impacted state budgets, causing across-the-board program cuts and reassessment of priorities. The bioscience industry was not immune to the crisis, but did begin to rebound much faster than many other industries. Because the biosciences remain a source of high-wage, high-skill jobs, almost every state in the country is actively engaged in building fundamental industry infrastructure. State-sponsored programs to encourage investment and help bioscience companies leverage existing resources Read More >
Policies that Benefit Start-Ups Grow the Bio-Economy
The United States remains the land of entrepreneurialism despite our lingering economic troubles. To maintain our nation’s global leadership and drive job growth, we must continue to create policies that encourage and reward innovation in growth industries — including biotechnology. Jeffrey Bussgang, a general partner at the venture capital firm Flybridge Capital Partners contributed an interesting piece to Fortune/CNN Money in which he points out that start-up companies – not small businesses – are the Read More >
Doggonn It! This Kitty May Be Researchers’ New Best Friend
The glow-in-the-dark cat is out of the bag. Researchers at the Mayo Clinic in Rochester, Minnesota have genetically modified domestic cats to resist the feline form of AIDS. As reported in the journal Nature Methods, this new achievement is a milestone in the ongoing quest to protect humans from the virus. And yes, these kitties glow in the dark. A green fluorescent protein was added to a gene from rhesus macaque monkeys that is known Read More >
Registration Now Open for California Healthcare Institute’s Annual Meeting
Register Now for CHI Annual Meeting, Nov. 3, in San Francisco and Save Register now for CHI’s 2011 Annual Meeting, focused on the relationship between biomedical innovation and public policy, and receive early-bird savings to this signature event. The annual meeting, “Shifting Sands: Forces Reshaping the Biomedical Innovation Business Model,” takes place Thursday, Nov. 3, at San Francisco’s Julia Morgan Ballroom. The event will bring together hundreds of leading executives from biotechnology, medical device and Read More >
